This inventor holds 1 USPTO granted patent. Top assignee: Hormos Nutraceutical Oy Ltd.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Marja Mutanen: Innovator in Nutraceuticals
Introduction
Marja Mutanen is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of nutraceuticals, focusing on innovative methods for disease prevention and treatment. Her work is particularly relevant in the context of genetic conditions related to the APC gene.
Latest Patents
Marja Mutanen holds a patent for her invention titled "Decreasing the intracellular level of β-catenin by administering hydroxymatairesinol." This invention relates to a method for reducing the intracellular, especially nuclear, level of β-catenin in individuals. It also encompasses methods for preventing or treating diseases associated with a mutant APC gene or elevated levels of intracellular β-catenin. Additionally, her patent includes methods for screening subjects to determine if they carry a mutant APC gene and for diagnosing predispositions to related diseases.
Career Highlights
Marja is associated with Hormos Nutraceutical Oy Ltd., where she applies her expertise in developing innovative health solutions. Her work has garnered attention for its potential impact on treating conditions linked to genetic mutations.
Conclusion
Marja Mutanen's contributions to the field of nutraceuticals highlight her innovative spirit and dedication to improving health outcomes through scientific advancements. Her patent reflects a significant step forward in understanding and addressing genetic health issues.